Santa Fe / Minneapolis / New York / Neuroreport / Zurich / La Jolla / Parkville / Amsterdam / Frankfurt / Revheim / /
Company
Weisstaub NV / Proc Natl Acad Sci U S A / Goldman / Ford / National Computer Systems / Komatsu / /
Country
Switzerland / Netherlands / Australia / /
Currency
pence / USD / / /
Event
Product Issues / /
Facility
Brain Imaging Centre / University Hospital of Psychiatry / Montreal Neurological Institute / Arch Gen Psychiatry / University of Melbourne / University of Zürich / Heffter Research Institute / University of California / Heffter Research Center / /
IndustryTerm
visual processing / visual and serotonergic systems / visual processing preceding image recognition / illusory contour processing / visual object processing / sensory processing deficits / software package / imaging / dopamine systems / visual processing components / occipital-frontalhippocampal brain network / functional magnetic resonance imaging / treatment of Parkinson’s disease / latestage motion processing / possible site / /
Department of Psychiatry / University of Melbourne / University Hospital of Psychiatry / Society of Biological Psychiatry / Montreal Neurological Institute / Swiss Neuromatrix Foundation / University of Zürich / Imaging Centre / Heffter Research Institute / Division of Geriatric Psychiatry / Brain Imaging and Heffter Research Center / Swiss Federal Office for Public Health / University of California / San Diego / /
Person
Olivia L. Carter / Arch Neurol / R.D. Pascual-Marqui / Michael Kometer / B. Rael Cahn / David Andel / Arch Psychiatry / /
ARCHIVAL REPORTS The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations Michael Kometer, B. Rael Cahn, David Andel, Olivia L. Carter, and Franz X. Vollenweider